Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Investigating the role of receptor-interacting protein kinase-3 in adipose tissue and metabolic syndrome

EF 2022-23

Résumé
Obesity is a prevalent chronic disease associated with various metabolic conditions, particularly type 2 diabetes (T2D). Despite this, not all individuals that are obese have or will develop T2D, and this varying risk may be explained by differences in their fat tissue. Evidence suggests that the death of fat cells is a major contributor of metabolic syndrome, characterized by chronic, low-grade inflammation and loss of blood sugar control. Necroptosis is a highly inflammatory form of cell death involved in many diseases, and therefore also presumed to be involved in fat cell death. However, a key protein that executes necroptosis called receptor-interacting protein kinase-3 (RIPK3) was found to prevent inflammation in fat tissue and loss of blood sugar control. This suggests that 1) our understanding of necroptosis may not apply to fat tissue and 2) RIPK3 may have functions beyond necroptosis, specifically in fat tissue. The goal of my project is to investigate non-necroptotic functions of RIPK3 in fat tissue and metabolic syndrome. I hypothesize that the necroptotic functions of RIPK3 do not contribute to the death of fat cells and metabolic syndrome. Using human fat cells and mouse models of obesity, I will investigate the effects of having 1) RIPK3 that lacks the ability to execute necroptosis and 2) RIPK3 over-production on blood sugar control, weight gain, and inflammation in fat tissue. I expect that necroptosis-impaired RIPK3 and RIPK3 over-production will maintain or improve blood sugar control and protect against weight gain and inflammation in fat tissue. Understanding the potentially protective role of RIPK3 in fat tissue will help characterize targets in the treatment of obesity and T2D.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
486530
Name
Chan Carmen K
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the role of receptor-interacting protein kinase-3 in adipose tissue and metabolic syndrome
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adipose Tissue; Apoptosis; Cell Death; Cell Signalling; Glucose Regulation; Inflammation; Metabolic Syndrome; Necroptosis; Obesity; Type 2 Diabetes
Abstract
Obesity is a prevalent chronic disease associated with various metabolic conditions, particularly type 2 diabetes (T2D). Despite this, not all individuals that are obese have or will develop T2D, and this varying risk may be explained by differences in their fat tissue. Evidence suggests that the death of fat cells is a major contributor of metabolic syndrome, characterized by chronic, low-grade inflammation and loss of blood sugar control. Necroptosis is a highly inflammatory form of cell death involved in many diseases, and therefore also presumed to be involved in fat cell death. However, a key protein that executes necroptosis called receptor-interacting protein kinase-3 (RIPK3) was found to prevent inflammation in fat tissue and loss of blood sugar control. This suggests that 1) our understanding of necroptosis may not apply to fat tissue and 2) RIPK3 may have functions beyond necroptosis, specifically in fat tissue. The goal of my project is to investigate non-necroptotic functions of RIPK3 in fat tissue and metabolic syndrome. I hypothesize that the necroptotic functions of RIPK3 do not contribute to the death of fat cells and metabolic syndrome. Using human fat cells and mouse models of obesity, I will investigate the effects of having 1) RIPK3 that lacks the ability to execute necroptosis and 2) RIPK3 over-production on blood sugar control, weight gain, and inflammation in fat tissue. I expect that necroptosis-impaired RIPK3 and RIPK3 over-production will maintain or improve blood sugar control and protect against weight gain and inflammation in fat tissue. Understanding the potentially protective role of RIPK3 in fat tissue will help characterize targets in the treatment of obesity and T2D.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chan, Carmen K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~